ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) encompasses a subgroup of tumors defined by absence of estrogen and progesterone receptor expression and lack of amplification of the human epidermal receptor growth factor 2/erythroblastic oncogene B (HER2/ERBB2) gene.